Bronchoesophageal fistula formation after three courses of nivolumab for carcinoma of unknown primary with a subgroup of lung squamous cell carcinoma

Immune checkpoint inhibitors (ICIs) are widely used in both monotherapy and combination chemotherapy for various types of cancers. Nivolumab is the most popular among ICIs, and the number of adapted malignant diseases for nivolumab is increasing. Bronchoesophageal fistula formation is a serious comp...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oxf Med Case Reports
Autors principals: Nishiyama, Akihiro, Sakaguchi, Hiroyuki, Yanagimura, Naohiro, Suzuki, Chiaki, Otani, Sakiko, Tanimoto, Azusa, Yamashita, Kaname, Takeuchi, Shinji, Ohtsubo, Koushiro, Ikeda, Hiroko, Yano, Seiji
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7768526/
https://ncbi.nlm.nih.gov/pubmed/33391772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/omcr/omaa116
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars